
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Prostate Cancer - Genitourinary Disorders - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "be96312d-c6b1-430f-befa-204b9d6c7b25";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v1059914";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "e2e84d82-3bc4-482a-842a-7c6b1b00f605",
 VasontId : "v1059515"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "0bcdf978-ff04-423a-b5ea-497be0487ae7",
 VasontId : "v878844"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="be96312d-c6b1-430f-befa-204b9d6c7b25">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = 'f9438f89-504b-4997-894f-d2b2318dd5df';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Prostate Cancer
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/chandrasekar-thenappan.html">Thenappan Chandrasekar</a></strong>
 <p class="topic__authors--description">, MD, University of California, Davis</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Oct 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="185" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v1059926" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v1059929" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v1059972" class="topicmenu_mobile__paragraph">Treatment</a>
 </li>
 <li>
 <a href="#v1059969" class="topicmenu_mobile__paragraph">Prognosis</a>
 </li>
 <li>
 <a href="#v84916456" class="topicmenu_mobile__paragraph">Prevention</a>
 </li>
 <li>
 <a href="#v9116869" class="topicmenu_mobile__paragraph">Key Points</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Calculators (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Images (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (2)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="AJCC/TNM* Staging of Prostate Cancer*">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 AJCC/TNM* Staging of Prostate...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"9cfcf992-b157-45c7-ae32-d84f2f6ffe9f","Title":"AJCC%2FTNM%2A%20Staging%20of%20Prostate%20Cancer%2A","ShareUrlTitle":"ajcctnm-staging-of-prostate-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v60968895","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"AJCC%2FTNM%2A%20Staging%20of%20Prostate%20Cancer%2A","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="TNM Definitions for Prostate Cancer*">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 TNM Definitions for Prostate...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"de40c0fc-bacf-4b13-a85a-8301269473aa","Title":"TNM%20Definitions%20for%20Prostate%20Cancer%2A","ShareUrlTitle":"tnm-definitions-for-prostate-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v60969059","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"TNM%20Definitions%20for%20Prostate%20Cancer%2A","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v1059921" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination (DRE) or prostate-specific antigen (PSA) measurement and confirmed by transrectal ultrasound-guided biopsy. Screening is controversial and should involve shared decision-making. Prognosis for most patients with prostate cancer, especially when it is localized or regional (usually before symptoms develop), is very good; more men die with prostate cancer than of it. Treatment is with prostatectomy, radiation therapy, palliative measures (eg, hormonal therapy, radiation therapy, chemotherapy), or, for many older patients and even carefully selected younger patients, active surveillance.</div></p></div><span id="v1059923" class="anchor"></span><div class="para"> <p>Adenocarcinoma of the prostate is the most common nondermatologic cancer in men <span class='symbol'>></span> 50 in the United States. In the United States, it is estimated that about 288,300 new cases and about 34,700 deaths will occur in 2023 (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206606" data-toggle="tooltip" title="General references" data-id="4f507dc6-fb23-4f2f-959d-35b95453f271" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">1</a><span id="4f507dc6-fb23-4f2f-959d-35b95453f271" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206606"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Incidence increases with each decade of life; autopsy studies show prostate cancer in 15 to 60% of men aged 60 to 90 years old, with incidence increasing with age. The lifetime risk of being diagnosed with prostate cancer is 1 in 6. Median age at diagnosis is 72, and <span class='symbol'>></span> 60% of prostate cancers are diagnosed in men <span class='symbol'>></span> 65 (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206606" data-toggle="tooltip" title="General references" data-id="8aa831ae-9c05-4953-89ec-564011bb800f" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">1</a><span id="8aa831ae-9c05-4953-89ec-564011bb800f" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206606"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Risk is highest for Black men, in particular those from the Caribbean. Genetic risk factors include <i data-mmanualobjecttype='gene' '>BRCA1/2</i> mutations, <a href="./{068A867A-E1FD-4515-9940-CDB35B9CA0A4}.html" data-toggle="tooltip" title="Lynch Syndrome" data-id="95ec51c2-ebf2-4111-a3b9-7d9d37e303dd" data-itemid="068a867a-e1fd-4515-9940-cdb35b9ca0a4">Lynch syndrome</a><span id="95ec51c2-ebf2-4111-a3b9-7d9d37e303dd" class="d-none xref"> <span class="tooltip-container"> <a href="./{068A867A-E1FD-4515-9940-CDB35B9CA0A4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Lynch Syndrome </span> Lynch syndrome is an autosomal dominant disorder responsible for 2 to 3% of cases of colorectal cancer ( 1). Symptoms, initial diagnosis, and treatment are similar to other forms of colorectal... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, and family history of some hereditary breast and ovarian cancers.</p></div><span id="v1059924" class="anchor"></span><div class="para"> <p>Sarcoma of the prostate is rare, occurring primarily in children. Undifferentiated prostate cancer, squamous cell carcinoma, and ductal transitional carcinoma also occur infrequently. Prostatic intraepithelial neoplasia is considered a possible premalignant histologic change.</p></div><span id="v1059925" class="anchor"></span><div class="para"> <p>Hormonal influences contribute to the course of adenocarcinoma but almost certainly not to other types of prostate cancer. The effect of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>testosterone</span> supplements on the risk of prostate cancer remains controversial. Data suggest that <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>testosterone</span> supplements for treatment of symptomatic hypogonadism do not increase the risk of prostate cancer (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206606" data-toggle="tooltip" title="General references" data-id="b84366be-afe1-446e-af93-9726586e9c19" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">2</a><span id="b84366be-afe1-446e-af93-9726586e9c19" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206606"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>).</p></div> <section id="v36206605" class="topic__section GHead"> <span></span> <h2 id="" class="topic__header--section"> <span id="v36206606" class="anchor"></span> General references </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v60969767" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://cancerstatisticscenter.cancer.org/#!/cancer-site/Prostate">American Cancer Society, Cancer Statistics Center:</a> Prostate at a glance. Accessed September 10, 2023.</p></div></li><li class="topic__listitem"><span id="v84916412" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/26779889/">Boyle P, Koechlin A, Bota M, et al</a>: Endogenous and exogenous <span class="genericDrug" data-showrollover="false">testosterone</span> and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: A meta-analysis. <i>BJU Int</i> 118(5):731-741, 2016. doi: 10.1111/bju.13417 </p></div></li></ul></div> </div> </section> <section id="v1059926" class="topic__section FHead" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <h2 id="SymptomsAndSigns_v1059927" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v1059927" class="anchor"></span> Symptoms and Signs of Prostate Cancer </h2> <div class="topic__content"> <span id="v1059928" class="anchor"></span><div class="para"> <p>Prostate cancer usually progresses slowly and rarely causes symptoms until advanced. In advanced disease, hematuria and symptoms of <a href="./{630F57A4-DFC7-4AB3-BC06-A8351D3B460B}.html" data-toggle="tooltip" title="Obstructive Uropathy" data-id="b0101760-6bee-4252-a45d-d279cfa15396" data-itemid="630f57a4-dfc7-4ab3-bc06-a8351d3b460b">bladder outlet obstruction</a><span id="b0101760-6bee-4252-a45d-d279cfa15396" class="d-none xref"> <span class="tooltip-container"> <a href="./{630F57A4-DFC7-4AB3-BC06-A8351D3B460B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Obstructive Uropathy </span> Obstructive uropathy is structural or functional hindrance of normal urine flow, sometimes leading to renal dysfunction (obstructive nephropathy). Symptoms, less likely in chronic obstruction... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (eg, straining, hesitancy, weak or intermittent urine stream, a sense of incomplete emptying, terminal dribbling) or ureteral obstruction (eg, renal colic, flank pain, renal dysfunction) may appear. Bone pain, pathologic fractures, or spinal cord compression may result from osteoblastic metastases to bone (commonly pelvis, ribs, vertebral bodies).</p></div> </div> </section> <section id="v1059929" class="topic__section FHead"> <h2 id="Diagnosis_v1059930" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v1059930" class="anchor"></span> Diagnosis of Prostate Cancer </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1059934" class="anchor"></span><div class="para"> <p>Screening by <a href="./{DE5B363E-91C6-4F28-BBEB-59DD0F2F01B6}.html#v27415320" data-toggle="tooltip" title="Prostate-specific antigen (PSA) levels" data-id="67c949f2-e82d-4cec-a9e3-3d32d3b39a8d" data-itemid="de5b363e-91c6-4f28-bbeb-59dd0f2f01b6">prostate-specific antigen</a><span id="67c949f2-e82d-4cec-a9e3-3d32d3b39a8d" class="d-none xref"> <span class="tooltip-container"> <a href="./{DE5B363E-91C6-4F28-BBEB-59DD0F2F01B6}.html#v27415320"> <span class="tooltip-content"> <span class="tooltip-heading"> Prostate-specific antigen (PSA) levels </span> Benign prostatic hyperplasia (BPH) is nonmalignant adenomatous overgrowth of the periurethral prostate gland. Symptoms are those of bladder outlet obstruction—weak stream, hesitancy, urinary... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (PSA) with or without a digital rectal examination (DRE)</p></div></li><li class="topic__listitem"><span id="v1059936" class="anchor"></span><div class="para"> <p>Diagnosis by needle biopsy of the prostate (most common) or biopsy of metastatic lesion</p></div></li><li class="topic__listitem"><span id="v1059938" class="anchor"></span><div class="para"> <p>Grading by histology</p></div></li><li class="topic__listitem"><span id="v1059940" class="anchor"></span><div class="para"> <p>Staging by CT/MRI and bone scanning, possibly newer modalities such as prostate-specific membrane antigen (PSMA)–based PET-CT or using other PET agents</p></div></li></ul></div><span id="v1059941" class="anchor"></span><div class="para"> <p>Sometimes stony-hard induration or nodules are palpable during DRE, but the examination is often normal; induration and nodularity suggest cancer but must be differentiated from granulomatous prostatitis, prostate calculi, and other prostate disorders. Extension of induration to the seminal vesicles and lateral fixation of the gland suggest locally advanced prostate cancer. Prostate cancers detected by DRE tend to be large, and <span class='symbol'>></span> 50% extend through the capsule. </p></div><span id="v9116500" class="anchor"></span><div class="para"> <p>Diagnosis of prostate cancer requires histologic confirmation, most commonly by transrectal or transperineal ultrasound–guided needle biopsy, which can be done in an office with use of local anesthesia or in an operating room under sedation. Hypoechoic areas on ultrasound are more likely to represent cancer. Occasionally, prostate cancer is diagnosed incidentally in tissue removed during surgery for <a href="./{DE5B363E-91C6-4F28-BBEB-59DD0F2F01B6}.html" data-toggle="tooltip" title="Benign Prostatic Hyperplasia (BPH)" data-id="a867207f-1de1-4397-ba96-5b51208fb619" data-itemid="de5b363e-91c6-4f28-bbeb-59dd0f2f01b6">benign prostatic hyperplasia</a><span id="a867207f-1de1-4397-ba96-5b51208fb619" class="d-none xref"> <span class="tooltip-container"> <a href="./{DE5B363E-91C6-4F28-BBEB-59DD0F2F01B6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Benign Prostatic Hyperplasia (BPH) </span> Benign prostatic hyperplasia (BPH) is nonmalignant adenomatous overgrowth of the periurethral prostate gland. Symptoms are those of bladder outlet obstruction—weak stream, hesitancy, urinary... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (BPH). Multiparametric MRI can risk-stratify patients for the need for a biopsy and identify suspect areas that should be targeted. It is now commonly used before initial biopsy or in men who are on active surveillance. </p></div> <section id="v1059942" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1059930_v1059943" class="topic__header--subsection"> <span id="v1059943" class="anchor"></span> Screening </h3> <div class="topic__content"> <span id="v1059944" class="anchor"></span><div class="para"> <p>Most cancers today are found by screening with serum PSA levels (and sometimes DRE). Screening recommendations can vary, but screening is commonly done annually in men <span class='symbol'>></span> 50 years old and is sometimes begun earlier for men at high risk (eg, those with a family history of prostate cancer, Black men). Screening is not usually recommended for men with a life expectancy <span class='symbol'>< </span>10 to 15 years. </p></div><span id="v84916415" class="anchor"></span><div class="para"> <p>Abnormal findings are further investigated based on clinician and patient preferences. Multiparametric MRI can detect suspect lesions, and various urine and blood tests may help determine the need for prostate biopsy. </p></div><span id="v1059948" class="anchor"></span><div class="para"> <p>It is still not certain whether screening decreases morbidity; decreases in mortality appear likely (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206641" data-toggle="tooltip" title="Diagnosis references" data-id="3c5f78dc-52f7-43b2-a601-813086050b74" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">1</a><span id="3c5f78dc-52f7-43b2-a601-813086050b74" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206641"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>), but the number needed to screen is high. It remains unclear if any gains resulting from screening outweigh the decreases in quality of life resulting from treatment of asymptomatic cancers. Screening is recommended by some professional organizations and discouraged by others. A pooled analysis of ERSPC (European Randomized Study of Screening for Prostate Cancer) and PLCO (Prostate, Lung, Colorectal, and Ovarian) trial data suggests that screening in both trials demonstrated a reduction in prostate cancer mortality when controlling for differences in screening intensity despite the high rate of contamination in the control arm of PLCO (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206641" data-toggle="tooltip" title="Diagnosis references" data-id="24692a10-5295-4f5c-9901-9aa4e877ae69" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">2, 3</a><span id="24692a10-5295-4f5c-9901-9aa4e877ae69" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206641"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). As a result, in 2017, the United States Preventive Services Task Force (USPSTF) reconsidered their 2012 recommendation against screening for prostate cancer (Level D) with a possible benefit (Level C) in men less than 70 years of age. Based on recent data (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206641" data-toggle="tooltip" title="Diagnosis references" data-id="b6f9bcc1-c58b-463d-a2a7-8ccb41949808" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">4</a><span id="b6f9bcc1-c58b-463d-a2a7-8ccb41949808" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206641"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>), the decrease in prostate cancer-specific mortality associated with screening appears likely, but the number needed to screen is high.</p></div><span id="v84916418" class="anchor"></span><div class="para"> <p>The current USPSTF recommendation is that for men aged 55 to 69 years, the decision to undergo periodic prostate-specific antigen (PSA)–based screening for prostate cancer should be an individual one after discussing the potential benefits and harms of screening with a clinician (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206641" data-toggle="tooltip" title="Diagnosis references" data-id="bd60c738-099b-4833-b31c-da5357d74909" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">4</a><span id="bd60c738-099b-4833-b31c-da5357d74909" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206641"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Most patients with newly diagnosed prostate cancers have a normal DRE, and serum PSA measurement is not ideal as a screening test. Although PSA is elevated in 25 to 92% of patients with prostate cancer (depending on tumor volume), it also is moderately elevated in 30 to 50% of patients with <a href="./{DE5B363E-91C6-4F28-BBEB-59DD0F2F01B6}.html" data-toggle="tooltip" title="Benign Prostatic Hyperplasia (BPH)" data-id="2249e5c3-db1a-4982-8931-42bdd890ab75" data-itemid="de5b363e-91c6-4f28-bbeb-59dd0f2f01b6">benign prostatic hyperplasia</a><span id="2249e5c3-db1a-4982-8931-42bdd890ab75" class="d-none xref"> <span class="tooltip-container"> <a href="./{DE5B363E-91C6-4F28-BBEB-59DD0F2F01B6}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Benign Prostatic Hyperplasia (BPH) </span> Benign prostatic hyperplasia (BPH) is nonmalignant adenomatous overgrowth of the periurethral prostate gland. Symptoms are those of bladder outlet obstruction—weak stream, hesitancy, urinary... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (depending on prostate size and degree of obstruction), in some smokers, and for several weeks after <a href="./{AC0767A0-B05E-46FD-AE43-345CC499AA72}.html" data-toggle="tooltip" title="Prostatitis" data-id="e0f76a7e-948d-48b3-baae-fd134b6eb7f8" data-itemid="ac0767a0-b05e-46fd-ae43-345cc499aa72">prostatitis</a><span id="e0f76a7e-948d-48b3-baae-fd134b6eb7f8" class="d-none xref"> <span class="tooltip-container"> <a href="./{AC0767A0-B05E-46FD-AE43-345CC499AA72}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Prostatitis </span> Prostatitis refers to a disparate group of prostate disorders that manifests with a combination of predominantly irritative or obstructive urinary symptoms and perineal pain. Some cases result... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> or prostate manipulation (catheter, cystoscopy, prostate biopsy). Rarely, other activities such as sexual activity or extreme bicycle riding falsely elevate PSA.</p></div><span id="v36206614" class="anchor"></span><div class="para"> <p>A level of <span class='symbol'>≥ </span>4 ng/mL (4 micrograms [mcg]/L) is often considered an indication for biopsy in men <span class='symbol'>></span> 50 years old. Although very high levels are significant (suggesting extracapsular extension of the tumor or metastases) and likelihood of cancer increases with increasing PSA levels, there is no cut-off below which there is no risk. </p></div><span id="v1475685" class="anchor"></span><div class="para"> <p>In asymptomatic patients, positive predictive value for cancer is 67% for PSA <span class='symbol'>></span> 10 ng/mL (10 mcg/L) and 25% for PSA 4 to 10 ng/mL (4 to 10 mcg/L); recent evidence indicates a 15% prevalence of cancer in men<span class='symbol'> ≥</span> 55 years old with PSA <span class='symbol'>&lt</span> 4 ng/mL (4 mcg/L) and a 10% incidence with PSA between 0.6 and 1.0 ng/mL (0.6 and 1.0 mcg/L). However, cancer present in men with lower levels tends to be smaller and of lower grade, although high-grade cancer (Gleason score 7 to 10) can be present at any level of PSA; perhaps 15% of cancers manifesting with PSA <span class='symbol'>&lt</span> 4 ng/mL (4 mcg/L) are high grade. Although it appears that a cut-off of 4 ng/mL (4 mcg/L) will miss some potentially serious cancers, the cost and morbidity resulting from the increased number of biopsies necessary to find them are unclear.</p></div><span id="v1059949" class="anchor"></span><div class="para"> <p>The decision whether to biopsy may be helped by other PSA-related factors, even in the absence of a family history of prostate cancer. For example, the rate of change in PSA (PSA velocity) should be <span class='symbol'>&lt</span> 0.75 ng/mL/yr (0.75 mcg/L/yr; lower in younger patients). Biopsy is usually recommended for PSA velocities <span class='symbol'>></span> 0.75 ng/mL/yr (0.75 mcg/L/yr). Similarly, PSA density (PSA relative to prostate volume) can help guide need for biopsy; biopsy should be considered if values are <span class='symbol'>≥</span> 0.15 (or sometimes <span class='symbol'>≥</span> 0.10 ng/mL). </p></div><span id="v1059950" class="anchor"></span><div class="para"> <p>Assays that determine the free-to-total PSA ratio and complex PSA are more tumor specific than standard total PSA measurements and may reduce the frequency of biopsies in patients without cancer. Prostate cancer is associated with less free PSA; no standard cut-off has been established, but generally, levels <span class='symbol'>&lt</span> 10 to 20% warrant biopsy. Other isoforms of PSA and new markers for prostate cancer are being studied. None of these other uses of PSA answers all of the concerns about possibly triggering too many biopsies. Many new tests (eg, urinary prostate cancer antigen 3 [PCA-3], Prostate Health Index, 4Kscore, urinary SelectMDX, and others) are available commercially and may be useful in screening decisions.</p></div><span id="v1059951" class="anchor"></span><div class="para"> <p>Clinicians should discuss the risks and benefits of PSA testing with patients. Some patients prefer to eradicate cancer at all costs—no matter how low the potential for progression and possible metastasis—and may prefer annual PSA testing. Others may value quality of life highly and can accept some uncertainty; they may prefer less frequent (or no) PSA testing.</p></div><span id="v44606078" class="anchor"></span><div class="para"> <p>Men with newly diagnosed prostate cancer should be offered germline testing and genetic counseling if they have intraductal histology, metastatic or high-grade localized prostate cancer, a strong family history of prostate cancer, or a known family history of <i data-mmanualobjecttype='gene' '>BRCA1/2</i> mutations/Lynch syndrome/hereditary breast and ovarian cancer.</p></div> </div> </section> <section id="v1059952" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1059930_v1059953" class="topic__header--subsection"> <span id="v1059953" class="anchor"></span> Grading and staging </h3> <div class="topic__content"> <span id="v1059954" class="anchor"></span><div class="para"> <p>Grading, based on the resemblance of tumor architecture to normal glandular structure, helps define the aggressiveness of the tumor. Grading takes into account histologic heterogeneity in the tumor. The Gleason score is commonly used. The most prevalent pattern and the next most prevalent pattern are each assigned a grade of 1 to 5, and the two grades are added to produce a total score. Most experts consider a score <span class='symbol'>≤</span> 6 to be well differentiated, 7 moderately differentiated, and 8 to 10 poorly differentiated. The lower the score, the less aggressive and invasive the tumor and the better the prognosis. For localized tumors, the Gleason score helps predict the likelihood of capsular penetration, seminal vesicle invasion, and spread to lymph nodes. Gleason grades 1 and 2 have now been eliminated; as a result, the lowest score possible (3 + 3) is 6. However, a Gleason score of 6 does not sound low on a scale previously ranging from 2 to 10. </p></div><span id="v44606079" class="anchor"></span><div class="para"> <p>The <b>Gleason Grade Group</b> is a newer score to help communicate this to patients, and also to simplify pathologic grading. This new scoring system was accepted by the World Health Organization (WHO) in 2016:</p></div><span id="v36206615" class="anchor"></span><div class="para"> <p>Grade Group 1 = Gleason score 6 (3+3)</p></div><span id="v36206616" class="anchor"></span><div class="para"> <p>Grade Group 2 = Gleason score 7 (3+4)</p></div><span id="v36206617" class="anchor"></span><div class="para"> <p>Grade Group 3 = Gleason score 7 (4+3)</p></div><span id="v36206618" class="anchor"></span><div class="para"> <p>Grade Group 4 = Gleason score 8</p></div><span id="v36206619" class="anchor"></span><div class="para"> <p>Grade Group 5 = Gleason score 9 and 10</p></div><span id="v36206620" class="anchor"></span><div class="para"> <p>Gleason Grade Group, clinical stage, and PSA level together (using tables or nomograms) predict pathologic stage and prognosis better than any of them alone. </p></div><span id="v1059956" class="anchor"></span><div class="para"> <p>Prostate cancer is staged to define extent of the tumor (see tables <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"9cfcf992-b157-45c7-ae32-d84f2f6ffe9f","Title":"AJCC%2FTNM%2A%20Staging%20of%20Prostate%20Cancer%2A","ShareUrlTitle":"ajcctnm-staging-of-prostate-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v60968895","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAJCC%2FTNM%20Staging%20of%20Prostate%20Cancer%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> and <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"de40c0fc-bacf-4b13-a85a-8301269473aa","Title":"TNM%20Definitions%20for%20Prostate%20Cancer%2A","ShareUrlTitle":"tnm-definitions-for-prostate-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v60969059","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ETNM%20Definitions%20for%20Prostate%20Cancer%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> ). Transrectal ultrasonography (TRUS) or MRI of the prostate may provide information for staging, particularly about capsular penetration and seminal vesicle invasion. Patients with clinical stage T1c to T2a tumors, low Gleason score (<span class='symbol'>≤</span> 7), and PSA <span class='symbol'>&lt</span> 10 ng/mL (10 mcg/L) usually get no additional staging tests before proceeding to treatment. Radionuclide bone scans are rarely helpful for finding bone metastases (they are frequently abnormal because of the trauma of arthritic changes) until the PSA is <span class='symbol'>></span> 20 ng/mL (20 mcg/L) or unless the Gleason score is high (ie, <span class='symbol'>≥ </span>8 or [4 +3]). CT (or MRI) of the abdomen and pelvis is commonly done to assess pelvic and retroperitoneal lymph nodes if the Gleason score is 8 to 10 and the PSA is <span class='symbol'>></span> 10 ng/mL (10 mcg/L), or if the PSA is <span class='symbol'>></span> 20 ng/mL (20 mcg/L) with any Gleason score. Suspect lymph nodes can be further evaluated by using needle biopsy. An MRI may also help define the local extent of the tumor in patients with locally advanced prostate cancer (stage T3). The role of PSMA (prostate-specific membrane antigen) and fluciclovine F18 PET scanning for staging is evolving, but current guidelines (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206641" data-toggle="tooltip" title="Diagnosis references" data-id="cec8bead-d962-45a2-af34-80c694b5787a" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">1</a><span id="cec8bead-d962-45a2-af34-80c694b5787a" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206641"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>) now suggest that PSMA-PET and that PSMA-PET/CT or PSMA-PET/MRI can be effective first-line imaging studies (instead of conventional imaging studies) for intermediate or high-risk patients.</p></div><span id="v36206621" class="anchor"></span><div class="para"> <p>Elevated serum acid phosphatase—especially the enzymatic assay—correlates well with the presence of metastases, particularly in lymph nodes. However, this enzyme may also be elevated in benign prostatic hyperplasia (BPH); it may also be slightly elevated after vigorous prostatic massage and in the presence of <a href="./{2122755C-8771-4044-BBDA-CE815D775832}.html" data-toggle="tooltip" title="Multiple Myeloma" data-id="7c64702c-c217-44f7-b678-e2d740423c9a" data-itemid="2122755c-8771-4044-bbda-ce815d775832"> multiple myeloma</a><span id="7c64702c-c217-44f7-b678-e2d740423c9a" class="d-none xref"> <span class="tooltip-container"> <a href="./{2122755C-8771-4044-BBDA-CE815D775832}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Multiple Myeloma </span> Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue. Common manifestations include lytic lesions in bones that cause... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/u/l/multiple_myeloma_joyce_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Multiple Myeloma" loading="lazy"> </span> </a> </span> </span>, <a href="./{04367B28-7A60-48DE-A183-10469AC64BCD}.html" data-toggle="tooltip" title="Gaucher Disease" data-id="881a46dc-49e6-4f9b-993d-331908f8e429" data-itemid="04367b28-7a60-48de-a183-10469ac64bcd">Gaucher disease</a><span id="881a46dc-49e6-4f9b-993d-331908f8e429" class="d-none xref"> <span class="tooltip-container"> <a href="./{04367B28-7A60-48DE-A183-10469AC64BCD}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Gaucher Disease </span> Gaucher disease is a sphingolipidosis, an inherited disorder of metabolism, resulting from glucocerebrosidase deficiency, causing deposition of glucocerebroside and related compounds. Symptoms... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, and <a href="./{26F34E48-2271-425D-B495-01426A68163C}.html" data-toggle="tooltip" title="Overview of Hemolytic Anemia" data-id="04321c38-ea72-49f0-9c46-a2af30739649" data-itemid="26f34e48-2271-425d-b495-01426a68163c">hemolytic anemia</a><span id="04321c38-ea72-49f0-9c46-a2af30739649" class="d-none xref"> <span class="tooltip-container"> <a href="./{26F34E48-2271-425D-B495-01426A68163C}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Hemolytic Anemia </span> At the end of their normal life span (about 120 days), red blood cells (RBCs) are removed from the circulation. Hemolysis is defined as premature destruction and hence a shortened RBC life span... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/p/h/spherocytes_hemolytic_anemia_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Hemolytic Anemia" loading="lazy"> </span> </a> </span> </span>. It is rarely used today to guide treatment or to follow patients after treatment, especially because its value when done as a radioimmune assay (the way it is usually done) has not been established. Reverse transcriptase–polymerase chain reaction assays for circulating prostate cancer cells are being studied as staging and prognostic tools.</p></div> <span id="v44606082"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v60968896"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"9cfcf992-b157-45c7-ae32-d84f2f6ffe9f","Title":"AJCC%2FTNM%2A%20Staging%20of%20Prostate%20Cancer%2A","ShareUrlTitle":"ajcctnm-staging-of-prostate-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v60968895","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"AJCC%2FTNM%2A%20Staging%20of%20Prostate%20Cancer%2A","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="9cfcf992-b157-45c7-ae32-d84f2f6ffe9f"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '9cfcf992-b157-45c7-ae32-d84f2f6ffe9f' }, async: true, success: function (data) { $('#9cfcf992-b157-45c7-ae32-d84f2f6ffe9f').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> <span id="v9116728"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v60969060"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"de40c0fc-bacf-4b13-a85a-8301269473aa","Title":"TNM%20Definitions%20for%20Prostate%20Cancer%2A","ShareUrlTitle":"tnm-definitions-for-prostate-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v60969059","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"TNM%20Definitions%20for%20Prostate%20Cancer%2A","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="de40c0fc-bacf-4b13-a85a-8301269473aa"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'de40c0fc-bacf-4b13-a85a-8301269473aa' }, async: true, success: function (data) { $('#de40c0fc-bacf-4b13-a85a-8301269473aa').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v9116849" class="anchor"></span><div class="para"> <p>Risk of cancer spread can be estimated by tumor stage, Gleason score (Gleason Grade Group), and PSA level:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v9116852" class="anchor"></span><div class="para"> <p>Low risk: Stage <span class='symbol'>≤ </span>T2a, Gleason score <span class='symbol'>=</span> 6 (Gleason Grade Group 1), and PSA level <span class='symbol'>≤ </span>10 ng/mL (10 mcg/L)</p></div></li><li class="topic__listitem"><span id="v9116854" class="anchor"></span><div class="para"> <p>Intermediate risk: Stage T2b-c, Gleason score <span class='symbol'>=</span> 7 (Gleason Grade Group 2-3), or PSA level <span class='symbol'>≥</span> 10 (10 mcg/L) and <span class='symbol'>≤</span> 20 ng/mL (20 mcg/L)</p></div></li><li class="topic__listitem"><span id="v9116856" class="anchor"></span><div class="para"> <p>High risk: Stage <span class='symbol'>≥</span> T3, Gleason score <span class='symbol'>≥</span> 8 (Gleason Grade Group 4-5), or PSA <span class='symbol'>≥ </span>20 ng/mL (20 mcg/L)</p></div></li></ul></div><span id="v1059968" class="anchor"></span><div class="para"> <p>Both acid phosphatase and PSA levels decrease after treatment and increase with recurrence, but PSA is the most sensitive marker for monitoring cancer progression and response to treatment and has virtually replaced acid phosphatase for this purpose.</p></div> </div> </section> <section id="v36206640" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1059930_v36206641" class="topic__header--subsection"> <span id="v36206641" class="anchor"></span> Diagnosis references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84916426" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/37029074/">de Vos II, Meertens A, Hogenhout R, et al</a>: A detailed evaluation of the effect of prostate-specific antigen-based screening on morbidity and mortality of prostate cancer: 21-year follow-up results of the Rotterdam section of the European Randomised Study of Screening for Prostate Cancer. <i>Eur Urol</i> 84(4):426-434, 2023. doi: 10.1016/j.eururo.2023.03.016</p></div></li><li class="topic__listitem"><span id="v84916429" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="http://www.erspc.org/">European Randomized Study of Screening for Prostate Cancer.</a> Accessed September 10, 2023.</p></div></li><li class="topic__listitem"><span id="v60969778" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/27144870/">Shoag JE, Mittal S, Hu JC</a>: Reevaluating PSA testing rates in the PLCO trial. <i>N Engl J Med</i> 374(18):1795-1796, 2016. doi: 10.1056/NEJMc1515131 </p></div></li><li class="topic__listitem"><span id="v84916432" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening">U.S. Preventive Services Task Force</a>: Prostate cancer: Screening. Final recommendation statement. Accessed September 6, 2023.</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1059972" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v1059973" class="topic__header--section" data-originaltitle="Treatment"> <span id="v1059973" class="anchor"></span> Treatment of Prostate Cancer </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1059977" class="anchor"></span><div class="para"> <p>For localized cancer within the prostate, surgery, radiation therapy, or active surveillance </p></div></li><li class="topic__listitem"><span id="v1059979" class="anchor"></span><div class="para"> <p>For cancer outside of the prostate, palliation with hormonal therapy, radiation therapy, or chemotherapy</p></div></li><li class="topic__listitem"><span id="v1059981" class="anchor"></span><div class="para"> <p>For some men who have low-risk cancers, active surveillance without treatment</p></div></li></ul></div><span id="v1059982" class="anchor"></span><div class="para"> <p>Treatment is guided by prostate-specific antigen (PSA) level, grade and stage of tumor, patient age, coexisting disorders, life expectancy, and patient preferences. The goal of therapy can be</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1059985" class="anchor"></span><div class="para"> <p>Active surveillance</p></div></li><li class="topic__listitem"><span id="v1059987" class="anchor"></span><div class="para"> <p>Local (aimed at cure)</p></div></li><li class="topic__listitem"><span id="v1059989" class="anchor"></span><div class="para"> <p>Systemic (aimed at decreasing or limiting tumor extent) and extending quantity and quality of life</p></div></li></ul></div><span id="v1059990" class="anchor"></span><div class="para"> <p>Many patients, regardless of age, prefer definitive therapy if cancer is life-threatening and potentially curable. However, therapy is palliative rather than definitive if cancer has spread outside the prostate because cure is unlikely. Active surveillance can be used for men unlikely to benefit from definitive therapy (eg, because of older age or comorbidity); these patients are treated with palliative measures if symptoms develop.</p></div> <section id="v1059991" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1059973_v1059992" class="topic__header--subsection"> <span id="v1059992" class="anchor"></span> Active surveillance </h3> <div class="topic__content"> <span id="v1059993" class="anchor"></span><div class="para"> <p>Active surveillance is appropriate for many asymptomatic patients with low-risk, or possibly even intermediate-risk, localized prostate cancer or if life-limiting disorders coexist; in these patients, risk of death due to other causes is greater than that due to prostate cancer. This approach requires periodic digital rectal examination (DRE), PSA measurement, and monitoring of symptoms. In healthy younger men with low-risk cancer, active surveillance also requires periodic repeat biopsies. The optimal interval between biopsies has not been established, but most experts agree that it should be <span class='symbol'>≥</span> 1 year, possibly less frequently if biopsies have been repeatedly negative. If the cancer progresses, treatment is required. About 30% of patients undergoing active surveillance eventually require therapy. In older men, active surveillance results in the same overall survival rate as prostatectomy; however, patients who had surgery have a significantly lower risk of distant metastases and disease-specific mortality.</p></div> </div> </section> <section id="v1059994" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1059973_v1059995" class="topic__header--subsection"> <span id="v1059995" class="anchor"></span> Local therapies </h3> <div class="topic__content"> <span id="v1059996" class="anchor"></span><div class="para"> <p>Local therapy is aimed at curing prostate cancer and may thus also be called definitive therapy. Radical prostatectomy, some forms of radiation therapy, and cryotherapy are the primary options. Careful counseling concerning the risks and benefits of these treatments and considerations of patient-specific characteristics (age, health, tumor characteristics) are critical in decision making.</p></div><span id="v1059997" class="anchor"></span><div class="para"> <p>Radical <b>prostatectomy</b> (removal of prostate with seminal vesicles and regional lymph nodes) is probably best for patients <span class='symbol'>&lt</span> 75 years old with a life expectancy of > 10 to 15 years and a tumor confined to the prostate. Prostatectomy is appropriate for some older men, based on life expectancy, coexisting disorders, and ability to tolerate surgery and anesthesia. Prostatectomy was historically done through an incision in the lower abdomen. Now, most prostatectomies are done via a robot-assisted laparoscopic approach that minimizes blood loss and hospital stay but has not been shown to alter morbidity or mortality. Complications of radical prostatectomy include urinary incontinence (which is severe in about 5 to 10%), bladder neck contracture or <a href="./{9E420687-087A-41A4-A7AB-4B752D3F46DA}.html" data-toggle="tooltip" title="Urethral Stricture" data-id="b2a7b643-615d-4bd1-a625-74aea94d0bd2" data-itemid="9e420687-087a-41a4-a7ab-4b752d3f46da">urethral stricture</a><span id="b2a7b643-615d-4bd1-a625-74aea94d0bd2" class="d-none xref"> <span class="tooltip-container"> <a href="./{9E420687-087A-41A4-A7AB-4B752D3F46DA}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Urethral Stricture </span> Urethral stricture is scarring that obstructs the anterior urethral lumen. Urethral stricture can be Congenital Acquired Anything that damages the urethral epithelium or corpus spongiosum can... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (in about 7 to 20%), <a href="./{43A56400-2B00-4417-A887-0799DF41C7F4}.html" data-toggle="tooltip" title="Erectile Dysfunction" data-id="eebf2010-c8e8-4ddc-9956-642a91d8c08c" data-itemid="43a56400-2b00-4417-a887-0799df41c7f4">erectile dysfunction</a><span id="eebf2010-c8e8-4ddc-9956-642a91d8c08c" class="d-none xref"> <span class="tooltip-container"> <a href="./{43A56400-2B00-4417-A887-0799DF41C7F4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Erectile Dysfunction </span> Erectile dysfunction is the inability to attain or sustain an erection satisfactory for sexual intercourse. Most erectile dysfunction is related to vascular, neurologic, psychologic, and hormonal... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (in about 30 to 100%—heavily dependent on age and current function), and rectal injury (in 1 to 2%). Nerve-sparing radical prostatectomy reduces the likelihood of erectile dysfunction but cannot always be done, depending on tumor stage and location.</p></div><span id="v1060001" class="anchor"></span><div class="para"> <p>Standard external beam <b> radiation therapy</b> usually delivers 70 grays (Gy) in 7 weeks, but this technique has been supplanted by conformal 3-dimensional radiation therapy and by intensity-modulated radiation therapy (IMRT), which safely deliver doses approaching 80 Gy to the prostate; data indicate that the rate of local control is higher, especially for high-risk patients. Some decrease in erectile function occurs in at least 40%. Other adverse effects include radiation proctitis, cystitis, diarrhea, fatigue, and possibly urethral strictures, particularly in patients with a prior history of transurethral resection of the prostate. Results with external-beam radiation therapy, radical prostatectomy, and active monitoring were shown to be comparable at a median of 10 years after treatment for localized prostate cancer, as demonstrated in the ProtecT trial (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206674" data-toggle="tooltip" title="Treatment references" data-id="13a34180-3050-4092-8354-74d0266a85fc" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">1</a><span id="13a34180-3050-4092-8354-74d0266a85fc" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206674"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). Newer forms of external radiation therapy such as proton therapy cost more, an expense that may not be justifiable given that the benefits in men with prostate cancer have not been clearly established. External beam radiation therapy also has a role if cancer is left after radical prostatectomy or if the PSA level begins to rise after surgery and no metastasis can be found. </p></div><span id="v84916434" class="anchor"></span><div class="para"> <p>Recent evidence (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206674" data-toggle="tooltip" title="Treatment references" data-id="cf8c23a0-8ed8-4c33-8f3a-b8c9ffce9549" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">2</a><span id="cf8c23a0-8ed8-4c33-8f3a-b8c9ffce9549" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206674"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>) also supports the use of radiation to the prostate in men with low-volume metastatic disease, often called <b>oligometastatic disease, </b>commonly defined as less than 3 to 5 metastatic sites. Recent advances in prostate cancer radiation therapy include the use of fiducial markers placed around the prostate to improve targeting. Hydrogel spacers can be placed by transrectal needle placement to help reduce rectal toxicity. The hydrogel spacers resorb with time. <b>Hypofractionation</b> is an evolving concept in radiation treatment, in which the total dose of radiation is divided into large doses and treatments are given once a day or less often. Hypofractionated radiation therapy is given over a shorter period of time (fewer days or weeks) than standard radiation therapy.</p></div><span id="v1060002" class="anchor"></span><div class="para"> <p><b>Brachytherapy</b> involves the implantation of radioactive seeds into the prostate through the perineum. These seeds emit a burst of radiation over a finite period (usually 3 to 6 months) and are then inert. Research protocols are examining whether high-quality implants used as monotherapy or implants plus external beam radiation therapy are superior for intermediate-risk patients. Brachytherapy also decreases erectile function, although onset may be delayed and patients may be more responsive to phosphodiesterase type 5 inhibitors than patients whose neurovascular bundles are resected or injured during surgery. Urinary frequency, urgency, and, less often, retention are common but usually subside over time. Other adverse effects include increased bowel movements; rectal urgency, bleeding, or ulceration; and prostatorectal fistulas.</p></div><span id="v84916436" class="anchor"></span><div class="para"> <p><b>Cryotherapy</b> (destruction of prostate cancer cells by freezing with cryoprobes, followed by thawing) is less well established; long-term outcomes are unknown. Adverse effects include <a href="./{630F57A4-DFC7-4AB3-BC06-A8351D3B460B}.html" data-toggle="tooltip" title="Obstructive Uropathy" data-id="5824d4b8-b59f-49fd-9009-caaa47f91b61" data-itemid="630f57a4-dfc7-4ab3-bc06-a8351d3b460b">bladder outlet obstruction</a><span id="5824d4b8-b59f-49fd-9009-caaa47f91b61" class="d-none xref"> <span class="tooltip-container"> <a href="./{630F57A4-DFC7-4AB3-BC06-A8351D3B460B}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Obstructive Uropathy </span> Obstructive uropathy is structural or functional hindrance of normal urine flow, sometimes leading to renal dysfunction (obstructive nephropathy). Symptoms, less likely in chronic obstruction... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{D4A51C7B-C445-4250-8447-DE3B1B20F0E8}.html" data-toggle="tooltip" title="Urinary Incontinence in Adults" data-id="5c3c9f8f-5813-448e-93cc-12bf543bdd0f" data-itemid="d4a51c7b-c445-4250-8447-de3b1b20f0e8">urinary incontinence</a><span id="5c3c9f8f-5813-448e-93cc-12bf543bdd0f" class="d-none xref"> <span class="tooltip-container"> <a href="./{D4A51C7B-C445-4250-8447-DE3B1B20F0E8}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Urinary Incontinence in Adults </span> Urinary incontinence is involuntary loss of urine; some experts consider it present only when a patient thinks it is a problem. The disorder is greatly underrecognized and underreported. Many... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{43A56400-2B00-4417-A887-0799DF41C7F4}.html" data-toggle="tooltip" title="Erectile Dysfunction" data-id="5716532a-d035-4fc5-92cc-5f6531d00924" data-itemid="43a56400-2b00-4417-a887-0799df41c7f4">erectile dysfunction</a><span id="5716532a-d035-4fc5-92cc-5f6531d00924" class="d-none xref"> <span class="tooltip-container"> <a href="./{43A56400-2B00-4417-A887-0799DF41C7F4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Erectile Dysfunction </span> Erectile dysfunction is the inability to attain or sustain an erection satisfactory for sexual intercourse. Most erectile dysfunction is related to vascular, neurologic, psychologic, and hormonal... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, and rectal pain or injury. Cryotherapy is not commonly the therapy of choice in the United States but may be used if radiation therapy is unsuccessful.</p></div><span id="v36206654" class="anchor"></span><div class="para"> <p><b>HIFU (high-intensity focused ultrasound)</b> uses intense ultrasound energy administered transrectally to ablate prostate tissue. It has been used for many years in Europe and Canada and has recently become more widely available in the United States. The role of this technology in the management of prostate cancer is evolving; presently, it appears to be best suited for radiation-recurrent prostate cancer or low-risk cancer with individual tumors that can be treated by focal therapy. Several other investigational therapies to treat focal lesions are under study, such as laser ablation and catheter electroporation.</p></div><span id="v9116857" class="anchor"></span><div class="para"> <p>If cancer localized to the prostate is high risk, various therapies may need to be combined (eg, for high-risk prostate cancer treated with external beam radiation, addition of hormonal therapy for periods varying from 6 months to 2 to 3 years).</p></div> </div> </section> <section id="v1060004" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1059973_v1060005" class="topic__header--subsection"> <span id="v1060005" class="anchor"></span> Systemic therapies </h3> <div class="topic__content"> <span id="v1060006" class="anchor"></span><div class="para"> <p>If cancer has spread beyond the prostate gland, cure is unlikely; systemic treatment aimed at decreasing or limiting tumor extent is usually given (<a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206674" data-toggle="tooltip" title="Treatment references" data-id="6d3771af-df23-4f39-969d-43f476dfd997" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">3</a><span id="6d3771af-df23-4f39-969d-43f476dfd997" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v36206674"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Prostate cancer is usually adenocarcinoma. Symptoms are typically absent until tumor growth causes hematuria and/or obstruction with pain. Diagnosis is suggested by digital rectal examination... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>). </p></div><span id="v1060007" class="anchor"></span><div class="para"> <p>Patients with a locally advanced tumor or metastases may benefit from androgen deprivation therapy (ADT) by castration, either surgically with bilateral orchiectomy or medically with luteinizing hormone–releasing hormone (LHRH) agonists, such as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>leuprolide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>goserelin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>triptorelin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>histrelin</span>, and buserelin, with or without radiation therapy. LHRH antagonists (eg, parenteral <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>degarelix</span>, oral <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>relugolix</span>) lower the <span class="genericDrug" data-showrollover="false">testosterone</span> level more rapidly than LHRH agonists. LHRH agonists and LHRH antagonists usually reduce serum <span class="genericDrug" data-showrollover="false">testosterone</span> almost as much as bilateral orchiectomy. Androgen-receptor targeted therapies (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>abiraterone</span> acetate with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prednisone</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enzalutamide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apalutamide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>darolutamide</span>) or chemotherapy (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>docetaxel</span>) can be given in combination with ADT; choice of therapy is determined by volume of metastatic disease and patient comorbidities. </p></div><span id="v36206657" class="anchor"></span><div class="para"> <p>All androgen-deprivation treatments cause loss of libido and <a href="./{43A56400-2B00-4417-A887-0799DF41C7F4}.html" data-toggle="tooltip" title="Erectile Dysfunction" data-id="69b3c144-d61c-45a6-a996-8e9496e5c7a2" data-itemid="43a56400-2b00-4417-a887-0799df41c7f4">erectile dysfunction</a><span id="69b3c144-d61c-45a6-a996-8e9496e5c7a2" class="d-none xref"> <span class="tooltip-container"> <a href="./{43A56400-2B00-4417-A887-0799DF41C7F4}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Erectile Dysfunction </span> Erectile dysfunction is the inability to attain or sustain an erection satisfactory for sexual intercourse. Most erectile dysfunction is related to vascular, neurologic, psychologic, and hormonal... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> and may cause <a href="./{D7CC01E9-54F0-450D-923F-38543AADBD7C}.html#v1062805" data-toggle="tooltip" title="Vasomotor" data-id="0d05cf4e-679c-4c98-afca-98e12cee8c15" data-itemid="d7cc01e9-54f0-450d-923f-38543aadbd7c">hot flushes</a><span id="0d05cf4e-679c-4c98-afca-98e12cee8c15" class="d-none xref"> <span class="tooltip-container"> <a href="./{D7CC01E9-54F0-450D-923F-38543AADBD7C}.html#v1062805"> <span class="tooltip-content"> <span class="tooltip-heading"> Vasomotor </span> Menopause is the permanent cessation of menses (amenorrhea) due to loss of ovarian follicular function. Clinical manifestations may include hot flushes, night sweats, sleep disruption, and genitourinary... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. LHRH agonists may cause PSA levels to increase temporarily. Some patients benefit from adding antiandrogens (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>flutamide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>bicalutamide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>nilutamide</span>, cyproterone acetate [not available in the United States]) for total androgen blockade. Combined androgen blockade usually refers to LHRH agonists plus antiandrogens, but its benefits appear minimally better than those of an LHRH agonist (or LHRH antagonist or orchiectomy) alone. Another approach is intermittent androgen blockade, which purports to delay emergence of androgen-independent prostate cancer and helps to limit some adverse effects of androgen deprivation. Total androgen ablation is given until PSA levels are reduced (usually to undetectable levels), then stopped. Treatment is started again when PSA levels rise above a certain threshold, although the ideal threshold is not yet defined. The optimal schedules for treatment and time-off treatment have not been determined and vary widely among practitioners. </p></div><span id="v36206660" class="anchor"></span><div class="para"> <p>Androgen deprivation may impair quality of life significantly (eg, self-image, attitude toward the cancer and its treatment, energy levels) and cause osteoporosis, anemia, and loss of muscle mass with long-term treatment. Exogenous estrogens are rarely used because they have a risk of cardiovascular and thromboembolic complications. </p></div><span id="v9116861" class="anchor"></span><div class="para"> <p>Hormonal therapy is effective in metastatic prostate cancer for a limited amount of time. Cancer that progresses (indicated by an increasing PSA level) despite a <span class="genericDrug" data-showrollover="false">testosterone</span> level consistent with castration (<span class='symbol'>&lt</span> 50 ng/dL [1.74 nmol/L]) is classified as <b>castrate-resistant prostate cancer.</b> Castrate-resistant prostate cancer (CRPC) can be further classified as M0 (nonmetastatic) CRPC or M1 (metastatic) prostate cancer. An increasing PSA despite low <span class="genericDrug" data-showrollover="false">testosterone</span> and absence of lesions on CT or bone scan is called nonmetastatic castrate-resistant prostate cancer. Risk of metastases is high. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Apalutamide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>darolutamide</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enzalutamide</span> are now available and can slow progression from M0 to M1 CRPC. Treatments that prolong survival in metastatic CRPC (most have been FDA approved since 2010) that should be combined with <span class="genericDrug" data-showrollover="false">testosterone</span> suppression include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v36206663" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Docetaxel</span> (a taxane chemotherapy drug)</p></div></li><li class="topic__listitem"><span id="v36206665" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Sipuleucel-T</span> (a patient-derived vaccine designed to induce immunity against prostate cancer cells)</p></div></li><li class="topic__listitem"><span id="v36206667" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Abiraterone</span> (which blocks androgen synthesis in the tumor as well as in the testes and adrenal glands)</p></div></li><li class="topic__listitem"><span id="v36206669" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Enzalutamide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>darolutamide</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>apalutamide</span> (which block binding of androgens to their receptors)</p></div></li><li class="topic__listitem"><span id="v36206671" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Cabazitaxel</span> (a taxane chemotherapy drug that may have activity in tumors that have become resistant to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>docetaxel</span>)</p></div></li><li class="topic__listitem"><span id="v44606382" class="anchor"></span><div class="para"> <p>Radium-233 (which emits alpha radiation, recently found to prolong survival as well as prevent complications due to bone metastases in men with CRPC)</p></div></li><li class="topic__listitem"><span id="v84916443" class="anchor"></span><div class="para"> <p>External beam radiation therapy (EBRT)</p></div></li><li class="topic__listitem"><span id="v44606385" class="anchor"></span><div class="para"> <p>PARP (poly [ADP-ribose]) inhibitors (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olaparib</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>rucaparib</span>), which appear active when used as monotherapy in patients with mCRPC and BRCA1/2 and other mutations. The PARP inhibitor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>talazoparib</span> is available in combination with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>enzalutamide</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olaparib</span> is now also used in combination with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>abiraterone</span>/<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>prednisone</span> as well with BRCA-mutated metastatic castration-resistant prostate cancer.</p></div></li><li class="topic__listitem"><span id="v84916445" class="anchor"></span><div class="para"> <p>Lutetium Lu 177 vipivotide tetraxetan, which specifically targets a molecule on the surface of prostate cancer cells and is given with a PSMA-positive PET/CT scan.</p></div></li></ul></div><span id="v36206672" class="anchor"></span><div class="para"> <p>Some data suggest that <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>sipuleucel-T</span> should be used at the earliest sign of CRPC with low PSA and no major symptoms of metastatic cancer (eg, pain). In general, treatments for CRPC are being tried earlier during the course of prostate cancer and are now showing benefit in hormone-sensitive metastatic prostate cancer. However, choice of treatment may involve many factors, and few data may be available to help predict results; thus familiarity with current clinical trials, patient education, and shared decision-making are recommended. </p></div><span id="v9116868" class="anchor"></span><div class="para"> <p>To help treat and prevent complications due to <b>bone metastases</b> (eg, pathologic fractures, pain, spinal cord compression), an osteoclast inhibitor (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>denosumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>zoledronic acid</span>) can be used. All men on ADT should be given <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>vitamin D</span> and calcium supplements with the selective use of DEXA scans to detect osteoporosis or osteopenia. Weight-bearing exercise may also help maintain weight, bone density, muscle mass, and core strength. Traditional external beam radiation therapy has been used to treat individual bone metastases. </p></div> </div> </section> <section id="v36206673" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Treatment_v1059973_v36206674" class="topic__header--subsection"> <span itemprop="name" id="v36206674" class="anchor"></span> Treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v84916447" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/27626136">Hamdy FC, Donovan JL, Lane JA, et al</a>: 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. <i>N Engl Med</i> 375(15):1415-1424, 2016. doi: 10.1056/NEJMoa1606220 </p></div></li><li class="topic__listitem"><span id="v84916451" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/30355464/">Parker CC, James ND, Brawley CD, et al</a>: Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): A randomised controlled phase 3 trial. <i>Lancet</i> 392(10162):2353-2366, 2018. doi: 10.1016/S0140-6736(18)32486-3</p></div></li><li class="topic__listitem"><span id="v84916454" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856730/">Posdzich P, Darr C, Hilser T, et al</a>: Metastatic prostate cancer—A review of current treatment options and promising new approaches. <i>Cancers</i> 15(2):461, 2023. https://doi.org/10.3390/cancers15020461</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1059969" class="topic__section FHead"> <h2 id="Prognosis_v1059970" class="topic__header--section" data-originaltitle="Prognosis"> <span id="v1059970" class="anchor"></span> Prognosis for Prostate Cancer </h2> <div class="topic__content"> <span id="v1059971" class="anchor"></span><div class="para"> <p>Prognosis for most patients with prostate cancer, especially when it is localized or regional, is very good. Life expectancy for older men with prostate cancer may differ little from age-matched men without prostate cancer, depending on their age and comorbidities. For many patients, long-term local control, or even cure, is possible. Potential for cure, even when cancer is clinically localized, depends on the tumor’s grade and stage. Without early treatment, patients with high-grade, poorly differentiated cancer have a poor prognosis. Undifferentiated prostate cancer, squamous cell carcinoma, and ductal transitional carcinoma respond poorly to conventional therapies. Metastatic cancer has no cure but may be sent into remission for many years using newer therapies. Median life expectancy with metastatic disease is typically 1 to 3 years, with some patients living for many years.</p></div> </div> </section> <section id="v84916456" class="topic__section FHead" itemprop="primaryPrevention" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="" class="topic__header--section" data-originaltitle="Prevention"> <span id="v84916457" class="anchor"></span> Prevention of Prostate Cancer </h2> <div class="topic__content"> <span id="v84916459" class="anchor"></span><div class="para"> <p>No measures reliably prevent prostate cancer. However, suggestions that following a healthy lifestyle—which includes exercising, eating a well-balanced diet (limiting red meat and saturated fats and eating abundant green leafy vegetables), limiting alcohol intake, and not smoking—is considered a reasonable approach.</p></div> </div> </section> <section id="v9116869" class="topic__section topic__section--keypoints FHead"> <h2 id="KeyPoints_v9116870" class="topic__header--section"> <span id="v9116870" class="anchor"></span> Key Points <span class="topic__keypoints--icon"></span> </h2> <div class="topic__content--keypoints"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v9116873" class="anchor"></span><div class="para"> <p>Prostate cancer develops very commonly with aging but is not always clinically important.</p></div></li><li class="topic__listitem"><span id="v9116875" class="anchor"></span><div class="para"> <p>Symptoms develop only after the cancer has enlarged enough to be more difficult to cure.</p></div></li><li class="topic__listitem"><span id="v9116877" class="anchor"></span><div class="para"> <p>Complications due to bone metastases are common and consequential.</p></div></li><li class="topic__listitem"><span id="v9116879" class="anchor"></span><div class="para"> <p>Diagnose prostate cancer by transrectal or transperineal ultrasound-guided needle biopsy.</p></div></li><li class="topic__listitem"><span id="v9116881" class="anchor"></span><div class="para"> <p>Discuss advantages and disadvantages of screening in men <span class='symbol'>></span> age 50 with life expectancy <span class='symbol'>></span> 10 or 15 years.</p></div></li><li class="topic__listitem"><span id="v9116883" class="anchor"></span><div class="para"> <p>For localized prostate cancer, consider local, curative treatment (eg, prostatectomy, radiation therapy) and active surveillance.</p></div></li><li class="topic__listitem"><span id="v9116885" class="anchor"></span><div class="para"> <p>For cancer that has spread beyond the prostate, consider systemic treatments (eg, various hormonal therapies, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>sipuleucel-T</span>, taxane chemotherapy).</p></div></li><li class="topic__listitem"><span id="v9116887" class="anchor"></span><div class="para"> <p>For bone metastases, consider radium-233 and osteoclast inhibitors.</p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="185">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '185',
 title: 'Prostate Cancer',
 itemGuid: 'be96312d-c6b1-430f-befa-204b9d6c7b25'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{1617DC75-36FD-42D7-B788-57DA463DBA35}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Penile Cancer</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{5E6D42D8-9B57-40F3-BCD5-EE4C132B9680}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Renal Cell Carcinoma</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="ea31ccb8-3377-4f82-855a-19ee4a4819db_mobile" usemap="#ea31ccb8-3377-4f82-855a-19ee4a4819db_mobile" width="326" height="90">
 <map name="ea31ccb8-3377-4f82-855a-19ee4a4819db_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="ea31ccb8-3377-4f82-855a-19ee4a4819db_tablet" usemap="#ea31ccb8-3377-4f82-855a-19ee4a4819db_tablet" width="326" height="90">
 <map name="ea31ccb8-3377-4f82-855a-19ee4a4819db_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="ea31ccb8-3377-4f82-855a-19ee4a4819db_desktop" usemap="#ea31ccb8-3377-4f82-855a-19ee4a4819db_desktop" width="326" height="90">
 <map name="ea31ccb8-3377-4f82-855a-19ee4a4819db_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd03
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="BE96312DC6B1430FBEFA204B9D6C7B25">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v60968895'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v60968896"></span> <div class="TableFullPage" id="v60968895"> <h3 class="title">AJCC/TNM* Staging of Prostate Cancer*</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v60968907" class="anchor"></span><div class="para"> <p>Stage</p></div></th><th style='text-align:left' scope='col'><span id="v60968909" class="anchor"></span><div class="para"> <p>Tumor</p></div></th><th style='text-align:left' scope='col'><span id="v60968911" class="anchor"></span><div class="para"> <p>Regional Lymph Nodes</p></div></th><th style='text-align:left' scope='col'><span id="v60968913" class="anchor"></span><div class="para"> <p>Distant Metastasis</p></div></th><th style='text-align:left' scope='col'><span id="v60968915" class="anchor"></span><div class="para"> <p>Prostate-Specific Antigen Level†</p></div></th><th style='text-align:left' scope='col'><span id="v60968917" class="anchor"></span><div class="para"> <p>Gleason Grade Group‡</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v60968932" class="anchor"></span><div class="para"> <p>I</p></div></td><td><span id="v60968934" class="anchor"></span><div class="para"> <p>cT1, cT2a, or pT2</p></div></td><td><span id="v60968936" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60968938" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60968940" class="anchor"></span><div class="para"> <p><></p></div></td><td><span id="v60968942" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v60968945" class="anchor"></span><div class="para"> <p>IIA</p></div></td><td><span id="v60968947" class="anchor"></span><div class="para"> <p>cT1, cT2a or pT2</p></div></td><td><span id="v60968949" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60968951" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60968953" class="anchor"></span><div class="para"> <p>≥ 10 but <20></20></p></div></td><td><span id="v60968955" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v60968958" class="anchor"></span><div class="para"> <p>cT2b or cT2c</p></div></td><td><span id="v60968960" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60968962" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60968964" class="anchor"></span><div class="para"> <p><span class='symbol'></span> 20</p></div></td><td><span id="v60968966" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v60968969" class="anchor"></span><div class="para"> <p>IIB</p></div></td><td><span id="v60968971" class="anchor"></span><div class="para"> <p>T1, T2</p></div></td><td><span id="v60968973" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60968975" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60968977" class="anchor"></span><div class="para"> <p>< 20></p></div></td><td><span id="v60968979" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v60968982" class="anchor"></span><div class="para"> <p>IIC</p></div></td><td><span id="v60968984" class="anchor"></span><div class="para"> <p>T1, T2</p></div></td><td><span id="v60968986" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60968988" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60968990" class="anchor"></span><div class="para"> <p><></p></div></td><td><span id="v60968992" class="anchor"></span><div class="para"> <p>3 or 4</p></div></td></tr><tr class="even"><td><span id="v60968995" class="anchor"></span><div class="para"> <p>IIIA</p></div></td><td><span id="v60968997" class="anchor"></span><div class="para"> <p>T1, T2</p></div></td><td><span id="v60968999" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60969001" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60969003" class="anchor"></span><div class="para"> <p>≥ 20 </p></div></td><td><span id="v60969005" class="anchor"></span><div class="para"> <p>1-4</p></div></td></tr><tr class="odd"><td><span id="v60969008" class="anchor"></span><div class="para"> <p>IIIB</p></div></td><td><span id="v60969010" class="anchor"></span><div class="para"> <p>T3, T4</p></div></td><td><span id="v60969012" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60969014" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60969016" class="anchor"></span><div class="para"> <p>Any PSA</p></div></td><td><span id="v60969018" class="anchor"></span><div class="para"> <p>1-4</p></div></td></tr><tr class="even"><td><span id="v60969021" class="anchor"></span><div class="para"> <p>IIIC</p></div></td><td><span id="v60969023" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v60969025" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60969027" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60969029" class="anchor"></span><div class="para"> <p>Any PSA</p></div></td><td><span id="v60969031" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="odd"><td><span id="v60969034" class="anchor"></span><div class="para"> <p>IVA</p></div></td><td><span id="v60969036" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v60969038" class="anchor"></span><div class="para"> <p>N1</p></div></td><td><span id="v60969040" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60969042" class="anchor"></span><div class="para"> <p>Any PSA</p></div></td><td><span id="v60969044" class="anchor"></span><div class="para"> <p>Any grade</p></div></td></tr><tr class="even"><td><span id="v60969047" class="anchor"></span><div class="para"> <p>IVB</p></div></td><td><span id="v60969049" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v60969051" class="anchor"></span><div class="para"> <p>Any N</p></div></td><td><span id="v60969053" class="anchor"></span><div class="para"> <p>M1</p></div></td><td><span id="v60969055" class="anchor"></span><div class="para"> <p>Any PSA</p></div></td><td><span id="v60969057" class="anchor"></span><div class="para"> <p>Any grade</p></div></td></tr></tbody> <tfoot><tr><td colspan="6"><span id="v60968921" class="anchor"></span><div class="para"> <p>* For AJCC/TNM definitions, see table <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v60969060" data-toggle="tooltip" title="TNM Definitions for Prostate Cancer*" data-id="11abde5e-3590-4cec-a1ed-4ca8cf1b0bf2" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">TNM Definitions for Prostate Cancer</a><span id="11abde5e-3590-4cec-a1ed-4ca8cf1b0bf2" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v60969060"> <span class="tooltip-content"> <span class="tooltip-heading"> TNM Definitions for Prostate Cancer* </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="/Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="TNM Definitions for Prostate Cancer*" loading="lazy"> </span> </a> </span> </span>. Data adapted from <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/staging.html">American Cancer Society, Prostate Cancer AJCC/TNM Staging System</a>. Accessed September 10, 2023.</p></div></td></tr><tr><td colspan="6"><span id="v60968925" class="anchor"></span><div class="para"> <p>† All PSA levels in this table represent both ng/mL and mcg/L (ie, 10 ng/mL = 10 mcg/L).</p></div></td></tr><tr><td colspan="6"><span id="v60968928" class="anchor"></span><div class="para"> <p>AJCC <span class='symbol'>=</span> American Joint Commission on Cancer; cT <span class='symbol'>= </span> clinical estimate of extent of disease (determined by physical exam, prostate biopsy, and imaging tests); PSA<span class='symbol'>=</span> prostate-specific antigen; pT = extent of disease that is based on <i>pathologic</i> examination of the prostate; TNM <span class='symbol'>=</span> tumor, node, metastasis.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v60969059'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v60969060"></span> <div class="TableFullPage" id="v60969059"> <h3 class="title">TNM Definitions for Prostate Cancer*</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v60969067" class="anchor"></span><div class="para"> <p>Feature</p></div></th><th style='text-align:left' scope='col'><span id="v60969069" class="anchor"></span><div class="para"> <p>Definition*</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v60969082" class="anchor"></span><div class="para"> <p>TX</p></div></td><td><span id="v60969084" class="anchor"></span><div class="para"> <p>Primary tumor not assessable</p></div></td></tr><tr class="even"><td><span id="v60969087" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="v60969089" class="anchor"></span><div class="para"> <p>No evidence of primary tumor</p></div></td></tr><tr class="odd"><td><span id="v60969092" class="anchor"></span><div class="para"> <p>T1</p></div></td><td><span id="v60969094" class="anchor"></span><div class="para"> <p>Not palpable and not seen with imaging test such as transrectal ultrasound</p></div></td></tr><tr class="even"><td><span id="v60969097" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v60969099" class="anchor"></span><div class="para"> <p>The tumor can be felt by digital rectal exam. Limited to prostate</p></div></td></tr><tr class="odd"><td><span id="v60969102" class="anchor"></span><div class="para"> <p>T2a</p></div></td><td><span id="v60969104" class="anchor"></span><div class="para"> <p>Involves <span class='symbol'>≤</span> half of lobe</p></div></td></tr><tr class="even"><td><span id="v60969107" class="anchor"></span><div class="para"> <p>T2b</p></div></td><td><span id="v60969109" class="anchor"></span><div class="para"> <p>Involves <span class='symbol'>></span> half of 1 lobe, but not both lobes</p></div></td></tr><tr class="odd"><td><span id="v60969112" class="anchor"></span><div class="para"> <p>T2c</p></div></td><td><span id="v60969114" class="anchor"></span><div class="para"> <p>Tumor involves both lobes</p></div></td></tr><tr class="even"><td><span id="v60969117" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v60969119" class="anchor"></span><div class="para"> <p>Extraprostatic extension</p></div></td></tr><tr class="odd"><td><span id="v60969122" class="anchor"></span><div class="para"> <p>T3a</p></div></td><td><span id="v60969124" class="anchor"></span><div class="para"> <p>Extends through the prostatic capsule unilaterally or bilaterally; microscopic invasion of the bladder neck</p></div></td></tr><tr class="even"><td><span id="v60969127" class="anchor"></span><div class="para"> <p>T3b</p></div></td><td><span id="v60969129" class="anchor"></span><div class="para"> <p>Invades seminal vesicles</p></div></td></tr><tr class="odd"><td><span id="v60969132" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v60969134" class="anchor"></span><div class="para"> <p>Is fixed or invades adjacent structures other than seminal vesicles</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v60969138" class="anchor"></span><div class="para"> <p>Regional lymph node metastasis</p></div></p></td></tr><tr class="odd"><td><span id="v60969141" class="anchor"></span><div class="para"> <p>NX</p></div></td><td><span id="v60969143" class="anchor"></span><div class="para"> <p>Not assessed</p></div></td></tr><tr class="even"><td><span id="v60969146" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60969148" class="anchor"></span><div class="para"> <p>None</p></div></td></tr><tr class="odd"><td><span id="v60969151" class="anchor"></span><div class="para"> <p>N1</p></div></td><td><span id="v60969153" class="anchor"></span><div class="para"> <p>Present</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v60969157" class="anchor"></span><div class="para"> <p>Distant metastasis</p></div></p></td></tr><tr class="odd"><td><span id="v60969160" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60969162" class="anchor"></span><div class="para"> <p>None</p></div></td></tr><tr class="even"><td><span id="v60969165" class="anchor"></span><div class="para"> <p>M1</p></div></td><td><span id="v60969167" class="anchor"></span><div class="para"> <p>Present</p></div></td></tr><tr class="odd"><td><span id="v60969170" class="anchor"></span><div class="para"> <p>M1a</p></div></td><td><span id="v60969172" class="anchor"></span><div class="para"> <p>Nonregional lymph nodes</p></div></td></tr><tr class="even"><td><span id="v60969175" class="anchor"></span><div class="para"> <p>M1b</p></div></td><td><span id="v60969177" class="anchor"></span><div class="para"> <p>Bone(s)</p></div></td></tr><tr class="odd"><td><span id="v60969180" class="anchor"></span><div class="para"> <p>M1c</p></div></td><td><span id="v60969182" class="anchor"></span><div class="para"> <p>Other site(s) with or without bone disease</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v60969073" class="anchor"></span><div class="para"> <p>* Data adapted from <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/staging.html">American Cancer Society, Prostate Cancer AJCC/TNM Staging System</a> and <a rel="nofollow" target="_blank" href="https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf">National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines), Prostate Cancer</a>. Accessed September 10, 2023. T2-T4 classified by pathologic criteria. There are no pathologic classifications of T1.</p></div></td></tr><tr><td colspan="2"><span id="v60969078" class="anchor"></span><div class="para"> <p>PSA = prostate-specific antigen; TNM = tumor, node, metastasis.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v60968895'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v60968896"></span> <div class="TableFullPage" id="v60968895"> <h3 class="title">AJCC/TNM* Staging of Prostate Cancer*</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v60968907" class="anchor"></span><div class="para"> <p>Stage</p></div></th><th style='text-align:left' scope='col'><span id="v60968909" class="anchor"></span><div class="para"> <p>Tumor</p></div></th><th style='text-align:left' scope='col'><span id="v60968911" class="anchor"></span><div class="para"> <p>Regional Lymph Nodes</p></div></th><th style='text-align:left' scope='col'><span id="v60968913" class="anchor"></span><div class="para"> <p>Distant Metastasis</p></div></th><th style='text-align:left' scope='col'><span id="v60968915" class="anchor"></span><div class="para"> <p>Prostate-Specific Antigen Level†</p></div></th><th style='text-align:left' scope='col'><span id="v60968917" class="anchor"></span><div class="para"> <p>Gleason Grade Group‡</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v60968932" class="anchor"></span><div class="para"> <p>I</p></div></td><td><span id="v60968934" class="anchor"></span><div class="para"> <p>cT1, cT2a, or pT2</p></div></td><td><span id="v60968936" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60968938" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60968940" class="anchor"></span><div class="para"> <p><></p></div></td><td><span id="v60968942" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v60968945" class="anchor"></span><div class="para"> <p>IIA</p></div></td><td><span id="v60968947" class="anchor"></span><div class="para"> <p>cT1, cT2a or pT2</p></div></td><td><span id="v60968949" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60968951" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60968953" class="anchor"></span><div class="para"> <p>≥ 10 but <20></20></p></div></td><td><span id="v60968955" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="odd"><td><span id="v60968958" class="anchor"></span><div class="para"> <p>cT2b or cT2c</p></div></td><td><span id="v60968960" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60968962" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60968964" class="anchor"></span><div class="para"> <p><span class='symbol'></span> 20</p></div></td><td><span id="v60968966" class="anchor"></span><div class="para"> <p>1</p></div></td></tr><tr class="even"><td><span id="v60968969" class="anchor"></span><div class="para"> <p>IIB</p></div></td><td><span id="v60968971" class="anchor"></span><div class="para"> <p>T1, T2</p></div></td><td><span id="v60968973" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60968975" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60968977" class="anchor"></span><div class="para"> <p>< 20=""></p></div></td><td><span id="v60968979" class="anchor"></span><div class="para"> <p>2</p></div></td></tr><tr class="odd"><td><span id="v60968982" class="anchor"></span><div class="para"> <p>IIC</p></div></td><td><span id="v60968984" class="anchor"></span><div class="para"> <p>T1, T2</p></div></td><td><span id="v60968986" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60968988" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60968990" class="anchor"></span><div class="para"> <p><></p></div></td><td><span id="v60968992" class="anchor"></span><div class="para"> <p>3 or 4</p></div></td></tr><tr class="even"><td><span id="v60968995" class="anchor"></span><div class="para"> <p>IIIA</p></div></td><td><span id="v60968997" class="anchor"></span><div class="para"> <p>T1, T2</p></div></td><td><span id="v60968999" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60969001" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60969003" class="anchor"></span><div class="para"> <p>≥ 20 </p></div></td><td><span id="v60969005" class="anchor"></span><div class="para"> <p>1-4</p></div></td></tr><tr class="odd"><td><span id="v60969008" class="anchor"></span><div class="para"> <p>IIIB</p></div></td><td><span id="v60969010" class="anchor"></span><div class="para"> <p>T3, T4</p></div></td><td><span id="v60969012" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60969014" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60969016" class="anchor"></span><div class="para"> <p>Any PSA</p></div></td><td><span id="v60969018" class="anchor"></span><div class="para"> <p>1-4</p></div></td></tr><tr class="even"><td><span id="v60969021" class="anchor"></span><div class="para"> <p>IIIC</p></div></td><td><span id="v60969023" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v60969025" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60969027" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60969029" class="anchor"></span><div class="para"> <p>Any PSA</p></div></td><td><span id="v60969031" class="anchor"></span><div class="para"> <p>5</p></div></td></tr><tr class="odd"><td><span id="v60969034" class="anchor"></span><div class="para"> <p>IVA</p></div></td><td><span id="v60969036" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v60969038" class="anchor"></span><div class="para"> <p>N1</p></div></td><td><span id="v60969040" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60969042" class="anchor"></span><div class="para"> <p>Any PSA</p></div></td><td><span id="v60969044" class="anchor"></span><div class="para"> <p>Any grade</p></div></td></tr><tr class="even"><td><span id="v60969047" class="anchor"></span><div class="para"> <p>IVB</p></div></td><td><span id="v60969049" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v60969051" class="anchor"></span><div class="para"> <p>Any N</p></div></td><td><span id="v60969053" class="anchor"></span><div class="para"> <p>M1</p></div></td><td><span id="v60969055" class="anchor"></span><div class="para"> <p>Any PSA</p></div></td><td><span id="v60969057" class="anchor"></span><div class="para"> <p>Any grade</p></div></td></tr></tbody> <tfoot><tr><td colspan="6"><span id="v60968921" class="anchor"></span><div class="para"> <p>* For AJCC/TNM definitions, see table <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v60969060" data-toggle="tooltip" title="TNM Definitions for Prostate Cancer*" data-id="11abde5e-3590-4cec-a1ed-4ca8cf1b0bf2" data-itemid="be96312d-c6b1-430f-befa-204b9d6c7b25">TNM Definitions for Prostate Cancer</a><span id="11abde5e-3590-4cec-a1ed-4ca8cf1b0bf2" class="d-none xref"> <span class="tooltip-container"> <a href="./{BE96312D-C6B1-430F-BEFA-204B9D6C7B25}.html#v60969060"> <span class="tooltip-content"> <span class="tooltip-heading"> TNM Definitions for Prostate Cancer* </span> <span class="tooltip-readmore"> </span> </span> <span class="tooltip-img"> <img src="/Content/Images/Redesign/table/icon_table_red.png?mh=160&mw=160" class="tooltip-Preview" alt="TNM Definitions for Prostate Cancer*" loading="lazy"> </span> </a> </span> </span>. Data adapted from <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/staging.html">American Cancer Society, Prostate Cancer AJCC/TNM Staging System</a>. Accessed September 10, 2023.</p></div></td></tr><tr><td colspan="6"><span id="v60968925" class="anchor"></span><div class="para"> <p>† All PSA levels in this table represent both ng/mL and mcg/L (ie, 10 ng/mL = 10 mcg/L).</p></div></td></tr><tr><td colspan="6"><span id="v60968928" class="anchor"></span><div class="para"> <p>AJCC <span class='symbol'>=</span> American Joint Commission on Cancer; cT <span class='symbol'>= </span> clinical estimate of extent of disease (determined by physical exam, prostate biopsy, and imaging tests); PSA<span class='symbol'>=</span> prostate-specific antigen; pT = extent of disease that is based on <i>pathologic</i> examination of the prostate; TNM <span class='symbol'>=</span> tumor, node, metastasis.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v60969059'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v60969060"></span> <div class="TableFullPage" id="v60969059"> <h3 class="title">TNM Definitions for Prostate Cancer*</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v60969067" class="anchor"></span><div class="para"> <p>Feature</p></div></th><th style='text-align:left' scope='col'><span id="v60969069" class="anchor"></span><div class="para"> <p>Definition*</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v60969082" class="anchor"></span><div class="para"> <p>TX</p></div></td><td><span id="v60969084" class="anchor"></span><div class="para"> <p>Primary tumor not assessable</p></div></td></tr><tr class="even"><td><span id="v60969087" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="v60969089" class="anchor"></span><div class="para"> <p>No evidence of primary tumor</p></div></td></tr><tr class="odd"><td><span id="v60969092" class="anchor"></span><div class="para"> <p>T1</p></div></td><td><span id="v60969094" class="anchor"></span><div class="para"> <p>Not palpable and not seen with imaging test such as transrectal ultrasound</p></div></td></tr><tr class="even"><td><span id="v60969097" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v60969099" class="anchor"></span><div class="para"> <p>The tumor can be felt by digital rectal exam. Limited to prostate</p></div></td></tr><tr class="odd"><td><span id="v60969102" class="anchor"></span><div class="para"> <p>T2a</p></div></td><td><span id="v60969104" class="anchor"></span><div class="para"> <p>Involves <span class='symbol'>≤</span> half of lobe</p></div></td></tr><tr class="even"><td><span id="v60969107" class="anchor"></span><div class="para"> <p>T2b</p></div></td><td><span id="v60969109" class="anchor"></span><div class="para"> <p>Involves <span class='symbol'>></span> half of 1 lobe, but not both lobes</p></div></td></tr><tr class="odd"><td><span id="v60969112" class="anchor"></span><div class="para"> <p>T2c</p></div></td><td><span id="v60969114" class="anchor"></span><div class="para"> <p>Tumor involves both lobes</p></div></td></tr><tr class="even"><td><span id="v60969117" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v60969119" class="anchor"></span><div class="para"> <p>Extraprostatic extension</p></div></td></tr><tr class="odd"><td><span id="v60969122" class="anchor"></span><div class="para"> <p>T3a</p></div></td><td><span id="v60969124" class="anchor"></span><div class="para"> <p>Extends through the prostatic capsule unilaterally or bilaterally; microscopic invasion of the bladder neck</p></div></td></tr><tr class="even"><td><span id="v60969127" class="anchor"></span><div class="para"> <p>T3b</p></div></td><td><span id="v60969129" class="anchor"></span><div class="para"> <p>Invades seminal vesicles</p></div></td></tr><tr class="odd"><td><span id="v60969132" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v60969134" class="anchor"></span><div class="para"> <p>Is fixed or invades adjacent structures other than seminal vesicles</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v60969138" class="anchor"></span><div class="para"> <p>Regional lymph node metastasis</p></div></p></td></tr><tr class="odd"><td><span id="v60969141" class="anchor"></span><div class="para"> <p>NX</p></div></td><td><span id="v60969143" class="anchor"></span><div class="para"> <p>Not assessed</p></div></td></tr><tr class="even"><td><span id="v60969146" class="anchor"></span><div class="para"> <p>N0</p></div></td><td><span id="v60969148" class="anchor"></span><div class="para"> <p>None</p></div></td></tr><tr class="odd"><td><span id="v60969151" class="anchor"></span><div class="para"> <p>N1</p></div></td><td><span id="v60969153" class="anchor"></span><div class="para"> <p>Present</p></div></td></tr><tr class="even" tablehead2=""><td colspan="2"><p class="tableHead2"><span id="v60969157" class="anchor"></span><div class="para"> <p>Distant metastasis</p></div></p></td></tr><tr class="odd"><td><span id="v60969160" class="anchor"></span><div class="para"> <p>M0</p></div></td><td><span id="v60969162" class="anchor"></span><div class="para"> <p>None</p></div></td></tr><tr class="even"><td><span id="v60969165" class="anchor"></span><div class="para"> <p>M1</p></div></td><td><span id="v60969167" class="anchor"></span><div class="para"> <p>Present</p></div></td></tr><tr class="odd"><td><span id="v60969170" class="anchor"></span><div class="para"> <p>M1a</p></div></td><td><span id="v60969172" class="anchor"></span><div class="para"> <p>Nonregional lymph nodes</p></div></td></tr><tr class="even"><td><span id="v60969175" class="anchor"></span><div class="para"> <p>M1b</p></div></td><td><span id="v60969177" class="anchor"></span><div class="para"> <p>Bone(s)</p></div></td></tr><tr class="odd"><td><span id="v60969180" class="anchor"></span><div class="para"> <p>M1c</p></div></td><td><span id="v60969182" class="anchor"></span><div class="para"> <p>Other site(s) with or without bone disease</p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v60969073" class="anchor"></span><div class="para"> <p>* Data adapted from <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/staging.html">American Cancer Society, Prostate Cancer AJCC/TNM Staging System</a> and <a rel="nofollow" target="_blank" href="https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf">National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines), Prostate Cancer</a>. Accessed September 10, 2023. T2-T4 classified by pathologic criteria. There are no pathologic classifications of T1.</p></div></td></tr><tr><td colspan="2"><span id="v60969078" class="anchor"></span><div class="para"> <p>PSA = prostate-specific antigen; TNM = tumor, node, metastasis.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>